Literature DB >> 6332155

Five-year absence of Pneumocystis carinii pneumonitis in a pediatric oncology center.

W T Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6332155     DOI： 10.1093/infdis/150.2.305-a

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  Diagnosing Pneumocystis carinii pneumonia by cytological examination of bronchoalveolar lavage fluid: report of 15 cases.

Authors:  J A Young; J W Stone; R J McGonigle; D Adu; J Michael
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

Review 2.  Pneumocystis carinii pneumonia.

Authors:  J T Macfarlane; R G Finch
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

3.  Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.

Authors:  W T Hughes
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

4.  Does cyclosporin A adversely affect Pneumocystis carinii infection?

Authors:  R J McGonigle; M Beaman; J Stone; J Young; J Michael; D Adu
Journal:  Postgrad Med J       Date:  1988-09       Impact factor: 2.401

Review 5.  Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors:  Martin Rodriguez; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 6.  Opportunistic infections in children following renal transplantation.

Authors:  W E Harmon
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

7.  Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.

Authors:  Su Young Kim; Alix A Dabb; Donald J Glenn; Kristen M Snyder; Meredith K Chuk; David M Loeb
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.